ARTICLE | Company News
Pharminox, Cancer Research UK deal
April 24, 2006 7:00 AM UTC
Cancer Research's Cancer Research Technology Ltd. subsidiary granted Pharminox an exclusive 12-month option to in-license exclusive worldwide rights to telomere signaling targeted agents. The lead com...